EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chronic Inflammatory Diseases and Cardiovascular Risk: Current Insights and Future Strategies for Optimal Management

Stefano Cacciatore iD, Silvia Andaloro iD, Marco Bernardi iD, Armando Oterino Manzanas, Luigi Spadafora iD, Stefano Figliozzi, Elad Asher iD, Jamal S Rana, Fiona Ecarnot iD, Felice Gragnano iD, Paolo Calabrò iD, Antonio Gallo iD und 8 weitere

International Journal of Molecular Sciences · 27.03.2025 · 26 (7) · 3071

DOI: 10.3390/ijms26073071 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.03.2025. Verfasst von Stefano Cacciatore und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Orthopedics and Rheumatology, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Inflammation. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università Cattolica del Sacro Cuore, European Commission, Centro Studi Achille e Linda Lorenzon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammation is a pivotal driver in the progression of atherosclerosis, significantly contributing to the burden of cardiovascular disease (CVD). Patients with chronic inflammatory diseases, such as inflammatory bowel diseases (IBDs) (e.g., ulcerative colitis and Crohn’s disease), rheumatological disorders, as well as individuals with auto-immune diseases (such as systemic lupus erythematosus), present a higher risk of major adverse cardiac events (MACEs). Despite their elevated CVD risk, these populations remain underrepresented in cardiovascular research, leading to a critical underestimation of their cardiovascular risk (CVR) in clinical practice. Furthermore, even recent CVR scores poorly predict the risk of events in these specific populations. This narrative review examines the physiopathological mechanisms linking chronic inflammation, immunomodulation, atherosclerosis, thrombosis and cardiovascular events. We review data from epidemiological studies and clinical trials to explore the potential cardiovascular benefits of anti-inflammatory and immunomodulatory therapies. Despite existing evidence, significant gaps in knowledge remain. Future research is mandatory, focusing on innovative strategies for risk stratification and optimization, including lipidomics, proteomics, advanced inflammatory markers, microbiota profiling, and cardiovascular imaging. Addressing these unmet needs will enhance understanding of cardiovascular risk in chronic inflammatory diseases, enabling tailored interventions and better outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesInflammationHumansChronic DiseaseHeart Disease Risk FactorsDisease ManagementAtherosclerosisRisk Factors

Stichwörter der Autor:innen

anti-inflammatory agentsatherosclerosisbiomarkerscardiovascular diseaseschronic inflammationimmunomodulationinflammatory bowel diseasesrheumatoid arthritisrisk assessmentsystemic lupus erythematosus

Autor:innen und Institutionen

  • Department of Geriatrics, Orthopedics and Rheumatology, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy.
  • Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy.
  • Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy.
  • Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica 79, 04100 Latina, Italy.
  • Department of Cardiology, Hospital Universitario de Salamanca-IBSAL, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain.
  • IRCCS Humanitas Research Hospital, Via Alessandro Manzoni, 56, Rozzano, 20089 Milano, Italy.

ORCID-Profile: Stefano Cacciatore, Silvia Andaloro, Marco Bernardi, Luigi Spadafora, Elad Asher, Fiona Ecarnot, Felice Gragnano, Paolo Calabrò, Antonio Gallo, Giuseppe Andò, Stephane Manzo-Silberman, Matteo Tosato, Giuseppe Biondi-Zoccai, Emanuele Marzetti, Pierre Sabouret

Förderung

  • Università Cattolica del Sacro Cuore
  • European Commission
  • Centro Studi Achille e Linda Lorenzon
  • Ministero della Salute
  • Next Generation EU PRIN
  • nonprofit research foundation Centro Studi Achille e Linda Lorenzon
  • Italian Ministry of Health

Zitieren

APA

Cacciatore, S., Andaloro, S., Bernardi, M., Oterino Manzanas, A., Spadafora, L., Figliozzi, S., Asher, E., Rana, J. S., Ecarnot, F., Gragnano, F., Calabrò, P., Gallo, A., Andò, G., Manzo-Silberman, S., Roeters van Lennep, J., Tosato, M., Landi, F., Biondi-Zoccai, G., Marzetti, E., & Sabouret, P. (2025). Chronic Inflammatory Diseases and Cardiovascular Risk: Current Insights and Future Strategies for Optimal Management. International Journal of Molecular Sciences, 26(7), 3071. https://doi.org/10.3390/ijms26073071

Vancouver

Cacciatore S, Andaloro S, Bernardi M, Oterino Manzanas A, Spadafora L, Figliozzi S, et al. Chronic Inflammatory Diseases and Cardiovascular Risk: Current Insights and Future Strategies for Optimal Management. International Journal of Molecular Sciences. 2025;26(7):3071. doi:10.3390/ijms26073071

BibTeX
@article{Cacciatore2025,
  author = {Cacciatore, Stefano and Andaloro, Silvia and Bernardi, Marco and Oterino Manzanas, Armando and Spadafora, Luigi and Figliozzi, Stefano and Asher, Elad and Rana, Jamal S and Ecarnot, Fiona and Gragnano, Felice and Calabrò, Paolo and Gallo, Antonio and Andò, Giuseppe and Manzo-Silberman, Stephane and Roeters van Lennep, Jeanine and Tosato, Matteo and Landi, Francesco and Biondi-Zoccai, Giuseppe and Marzetti, Emanuele and Sabouret, Pierre},
  title = {Chronic Inflammatory Diseases and Cardiovascular Risk: Current Insights and Future Strategies for Optimal Management},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {7},
  pages = {3071},
  doi = {10.3390/ijms26073071}
}
Kostenlos starten →